AI assistant
SPRUCE BIOSCIENCES, INC. — Director's Dealing 2020
Oct 9, 2020
35408_dirs_2020-10-08_16393604-6002-488f-aa16-d49e8f8a361e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: SPRUCE BIOSCIENCES, INC. (SPRB)
CIK: 0001683553
Period of Report: 2020-10-08
Reporting Person: GREY MICHAEL G (Director, Executive Chairman)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $0.85 | 2027-06-13 | Common Stock (68796) | Direct | |
| Stock Option (Right to Buy) | $1.44 | 2029-07-22 | Common Stock (29047) | Direct | |
| Stock Option (Right to Buy) | $1.64 | 2030-06-07 | Common Stock (94174) | Direct | |
| Stock Option (Right to Buy) | $3.07 | 2030-06-07 | Common Stock (112520) | Direct |
Footnotes
F1: The shares subject to the stock option vest over a four-year period commencing May 1, 2017, with 1/4th of the shares vesting on May 1, 2018 and 1/36th of the remaining shares vesting on a monthly basis.
F2: The shares subject to the stock option vest over a four-year period commencing March 1, 2019, with 1/4th of the shares vesting on March 1, 2020 and 1/36th of the remaining shares vesting on a monthly basis.
F3: All of the shares subject to the stock option are early exercisable, subject to the Issuer's right of repurchase. 12,994 of the shares subject to the stock option vest over a four-year period commencing February 19, 2020, with 1/48th of the shares vesting on a monthly basis following the closing of the Issuer's initial public offering, and 81,180 shares of which vest over a four-year period commencing February 19, 2020, with 1/48th of the shares vesting on a monthly basis.
F4: All of the shares subject to the stock option are early exercisable, subject to the Issuer's right of repurchase. 15,593 of the shares subject to the stock option vest over a four-year period commencing August 7, 2020, with 1/48th of the shares vesting on a monthly basis following the closing of the Issuer's initial public offering, and 96,927 shares of which vest over a four-year period commencing August 7, 2020, with 1/48th of the shares vesting on a monthly basis.